Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

Nearly half of patients with type 2 diabetes and two-thirds without discontinue GLP-1 receptor agonists within a year, with weight loss, income, and adverse events influencing discontinuation and ...

not only does it help with blood sugar control but also blood pressure, cholesterol and mobility—it can completely change people's lives around." GLP-1 receptor agonists stimulate the body to ...

I am, dear. I am John Rambo. Doctors don’t fully understand quite how semaglutides work, but they do have a good sketch of what they do. These drugs are known as GLP-1 agonists. GLP-1 is a naturally ...

This article asks whether peptides really work for ... it is safe to do so. Some of the most common peptides for weight loss are glucagon-like peptide 1 (GLP-1) receptor agonists.

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders. HealthDay News — For people with diabetes, the use of glucagon ...

Use of GLP-1 receptor agonists reduced the risk of kidney failure and individual MACE components compared with placebo among patients with or without diabetes. Glucagon-like peptide-1 receptor ...

Share on Pinterest Women with diabetes may get the strongest cardiovascular protection from GLP-1 agonists. Image credit: Kathryn Gamble for The Washington Post via Getty Images. Diabetes ...